Watch CEO of Immuta, Matthew Carroll's fireside chat with Alessandra De Almeida, Executive Director of Data Management & Governance at Merck, exploring Merck's transformative data management journey.

If we compare that back to 2021, that's almost a tripling of the number of assets that we have. And so from a commercial perspective, the reason I get excited is because the impact we can have on ...

Feel free to distribute or cite this material, but please credit OpenSecrets. For permission to reprint for commercial uses, such as textbooks, contact OpenSecrets: [email protected] ...

Merck’s cancer immunotherapy Keytruda is the drug industry’s biggest blockbuster, bringing in $25 billion in sales last year. For years drug companies have sought to beat the therapy to no avail.

Merck (NYSE: MRK) is a top pharmaceutical company coming off a good quarter that shows it is growing its top and bottom lines. Even with that growth, the stock still trades at a fairly modest ...

The trial will assess the asset in patients with diabetic macular oedema. Credit: NTshutterth / Shutterstock. MSD (Merck & Co) and its wholly-owned subsidiary EyeBio have announced the start of the ...

Credit: R Photography Background/Shutterstock. Merck & Co has received European Commission (EC) approval for the use of Keytruda (pembrolizumab) along with Padcev (enfortumab vedotin-ejfv) as a ...

Merck faces significant challenges, including increased competition and regulatory scrutiny for Keytruda. Keytruda is facing potential threats from competitors like Summit Therapeutics ...

You know the Detroit Lions have arrived when their head coach is starring in a commercial for a major restaurant chain. Dan Campbell was front and center in a new ad for Applebee's that was ...

We all still wanna be like Mike. Even with the onset of streaming, many advertising executives would argue there’s still no better way to sell a product than through a widely seen TV commercial.

Sept 3 (Reuters) - CapitaLand Integrated Commercial Trust (CMLT.SI), opens new tab will acquire a 50% stake in Singapore's ION Orchard mall for an agreed property value of S$1.85 billion ($1.42 ...